Jubilant Pharmova Limited
JUBLPHARMA · 530019 · Healthcare · Pharmaceuticals
- Market cap
- Rs 13,680 Cr
- P/E
- 34.43x
- P/B
- 1.93x
- 52W high / low
- Rs 1,184.8 / Rs 786.05
Our computed roe (5.97%) diverges from BSE's own published figure (2.75%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong. Our computed net_margin (4.80%) diverges from BSE's own published figure (81.37%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.
More
Peer comparison
Official BSE basic industry: Pharmaceuticals. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Cipla Limited | Rs 1,450 | Rs 1,17,138 Cr | Rs 29,159 Cr | Rs 3,356 Cr | 34.74x | 10.27% |
| Zydus Lifesciences Limited | Rs 1,135.2 | Rs 1,14,201 Cr | Rs 27,658 Cr | Rs 5,124 Cr | 22.66x | 19.74% |
| Lupin Limited | Rs 2,235 | Rs 1,02,195 Cr | Rs 30,442 Cr | Rs 5,551 Cr | 18.47x | 27.89% |
| Dr. Reddy's Laboratories Limited | Rs 1,200 | Rs 1,00,200 Cr | Rs 34,651 Cr | Rs 3,183 Cr | 31.02x | 9.02% |
| Mankind Pharma Limited | Rs 2,425.2 | Rs 1,00,112 Cr | Rs 14,636 Cr | Rs 1,938 Cr | 52.32x | 12.49% |
| Laurus Labs Limited | Rs 1,787.3 | Rs 96,487 Cr | Rs 6,868 Cr | Rs 890 Cr | 89.91x | 18.19% |
| Aurobindo Pharma Limited | Rs 1,622.1 | Rs 93,336 Cr | Rs 35,625 Cr | Rs 3,711 Cr | 25.35x | 10.53% |
| Biocon Limited | Rs 417 | Rs 67,954 Cr | Rs 17,638 Cr | Rs 416 Cr | — | 1.78% |
| Glenmark Pharmaceuticals Limited | Rs 2,318.4 | Rs 65,425 Cr | Rs 18,236 Cr | Rs 1,798 Cr | 36.39x | 15.46% |
| Alkem Laboratories Limited | Rs 5,368 | Rs 64,174 Cr | Rs 15,681 Cr | Rs 2,204 Cr | 29.75x | 16.72% |
| Abbott India Limited | Rs 27,060 | Rs 57,503 Cr | Rs 7,295 Cr | Rs 1,615 Cr | 35.61x | 35.85% |
| Gland Pharma Limited | Rs 2,970.2 | Rs 48,996 Cr | Rs 7,045 Cr | Rs 1,129 Cr | 43.35x | 11.57% |
| Ajanta Pharma Limited | Rs 3,672.8 | Rs 46,039 Cr | Rs 5,993 Cr | Rs 1,135 Cr | 40.43x | 27.19% |
| GlaxoSmithKline Pharmaceuticals Limited | Rs 2,688.8 | Rs 45,551 Cr | Rs 4,100 Cr | Rs 1,068 Cr | 43.36x | 50.64% |
| IPCA Laboratories Limited | Rs 1,734.2 | Rs 43,997 Cr | Rs 10,293 Cr | Rs 1,375 Cr | 33.59x | 17.45% |
| Jubilant Pharmova LimitedThis company | Rs 865.8 | Rs 13,680 Cr | Rs 8,346 Cr | Rs 398 Cr | 34.43x | 5.97% |
| Median | Rs 2,011.15 | Rs 78,755 Cr | Rs 12,465 Cr | Rs 1,776 Cr | 34.58x | 17.09% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.